Cited by

• Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

  Yates AJ, Saqr HE, Van Brocklyn J. Yates AJ, et al. J Neurooncol. 1995;24(1):65-73. doi: 10.1007/BF01052661. J Neurooncol. 1995. PMID: 8523078 Review.
• Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.

  Labrada M, Pablos I, Prete F, Hevia G, Clavell M, Benvenuti F, Fernández LE. Labrada M, et al. Hum Vaccin Immunother. 2014;10(8):2312-20. doi: 10.4161/hv.29161. Hum Vaccin Immunother. 2014. PMID: 25424937 Free PMC article.
• Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides.

  Ma R, Koulov A, Moulton C, Basu M, Banerjee S, Goodson H, Basu S. Ma R, et al. Glycoconj J. 2004;20(5):319-30. doi: 10.1023/B:GLYC.0000033628.39302.ae. Glycoconj J. 2004. PMID: 15229396
• Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.

  Mirkin BL, Clark SH, Zhang C. Mirkin BL, et al. Cell Prolif. 2002 Apr;35(2):105-15. doi: 10.1046/j.1365-2184.2002.00228.x. Cell Prolif. 2002. PMID: 11952645 Free PMC article.
• 1H NMR ganglioside ceramide resonance region on the differential diagnosis of low and high malignancy of brain gliomas.

  Lombardi V, Valko L, Valko M, Scozzafava A, Morris H, Melnik M, Svitel J, Budesinský M, Pelnár J, Steno J, Liptaj T, Zalibera L, Budinská J, Zlatos J, Giuliani A, Mascolo L, Leibfritz D, Troncone A, Marzullo F, Mazur M, Klener J, Zverina E. Lombardi V, et al. Cell Mol Neurobiol. 1997 Oct;17(5):521-35. doi: 10.1023/a:1026362922549. Cell Mol Neurobiol. 1997. PMID: 9353593 Free PMC article.